California Public Employees Retirement System Insmed Inc Transaction History

California Public Employees Retirement System

$140 Billion
Q1 2025

A detailed history of California Public Employees Retirement System transactions in Insmed Inc stock. As of the latest transaction made, California Public Employees Retirement System holds 265,477 shares of INSM stock, worth $25.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

265,477

Previous 256,355 3.56%

Holding current value

$25.9 Million

Previous $17.7 Million 14.44%

% of portfolio

0.01%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$65.25 - $83.83 $595,210 - $764,697	9,122 Added 3.56%	265,477 $20.3 Million
Q4 2024 Feb 12, 2025	SELL	$66.29 - $76.63 $167,183 - $193,260	-2,522 Reduced 0.97%	256,355 $17.7 Million
Q3 2024 Nov 13, 2024	BUY	$62.0 - $79.01 $3.96 Million - $5.04 Million	63,815 Added 32.72%	258,877 $18.9 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $95,590 - $302,889	4,345 Added 2.28%	195,062 $13.1 Million
Q1 2024 Apr 30, 2024	SELL	$25.72 - $29.94 $15,123 - $17,604	-588 Reduced 0.31%	190,717 $5.17 Million
Q4 2023 Feb 01, 2024	SELL	$23.42 - $31.74 $39,158 - $53,069	-1,672 Reduced 0.87%	191,305 $5.93 Million
Q3 2023 Nov 02, 2023	BUY	$19.86 - $26.93 $34,218 - $46,400	1,723 Added 0.9%	192,977 $4.87 Million
Q2 2023 Aug 09, 2023	SELL	$16.44 - $21.1 $630,375 - $809,058	-38,344 Reduced 16.7%	191,254 $4.04 Million
Q1 2023 May 12, 2023	SELL	$16.26 - $21.73 $110,649 - $147,872	-6,805 Reduced 2.88%	229,598 $3.91 Million
Q4 2022 Feb 08, 2023	SELL	$16.98 - $23.15 $222,353 - $303,149	-13,095 Reduced 5.25%	236,403 $4.72 Million
Q3 2022 Nov 09, 2022	BUY	$20.88 - $28.21 $701,380 - $947,602	33,591 Added 15.56%	249,498 $5.37 Million
Q1 2022 May 04, 2022	SELL	$20.42 - $28.13 $514,053 - $708,144	-25,174 Reduced 10.44%	215,907 $5.07 Million
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $55,456 - $71,649	2,142 Added 0.9%	241,081 $6.57 Million
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $273,832 - $359,298	12,192 Added 5.38%	238,939 $6.58 Million
Q2 2021 Aug 13, 2021	SELL	$24.17 - $36.01 $360,133 - $536,549	-14,900 Reduced 6.17%	226,747 $6.45 Million
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $347,300 - $476,623	-10,759 Reduced 4.26%	241,647 $8.23 Million
Q4 2020 Feb 02, 2021	BUY	$31.45 - $40.54 $726,023 - $935,865	23,085 Added 10.07%	252,406 $8.4 Million
Q3 2020 Nov 05, 2020	BUY	$26.0 - $34.5 $634,946 - $842,524	24,421 Added 11.92%	229,321 $7.37 Million
Q2 2020 Aug 12, 2020	BUY	$14.11 - $29.42 $330,174 - $688,428	23,400 Added 12.89%	204,900 $5.64 Million
Q1 2020 May 12, 2020	SELL	$13.63 - $33.98 $1.23 Million - $3.08 Million	-90,603 Reduced 33.3%	181,500 $2.91 Million
Q4 2019 Jan 27, 2020	BUY	$16.12 - $24.98 $2 Million - $3.1 Million	124,200 Added 83.97%	272,103 $6.5 Million
Q3 2019 Oct 31, 2019	BUY	$15.49 - $25.78 $536,279 - $892,529	34,621 Added 30.56%	147,903 $2.61 Million
Q2 2019 Aug 15, 2019	SELL	$23.0 - $32.19 $57,500 - $80,475	-2,500 Reduced 2.16%	113,282 $2.9 Million
Q1 2019 May 03, 2019	BUY	$13.91 - $31.15 $172,233 - $385,699	12,382 Added 11.97%	115,782 $3.37 Million
Q4 2018 Feb 08, 2019	SELL	$11.6 - $18.7 $270,280 - $435,710	-23,300 Reduced 18.39%	103,400 $1.36 Million
Q3 2018 Nov 13, 2018	SELL	$18.95 - $28.08 $178,130 - $263,952	-9,400 Reduced 6.91%	126,700 $2.56 Million
Q2 2018 Aug 15, 2018	SELL	$20.0 - $29.72 $230,000 - $341,780	-11,500 Reduced 7.79%	136,100 $3.22 Million
Q1 2018 May 11, 2018	BUY	$21.69 - $32.99 $1.32 Million - $2.01 Million	61,000 Added 70.44%	147,600 $3.32 Million
Q4 2017 Feb 06, 2018	BUY	$26.43 - $31.78 $105,720 - $127,120	4,000 Added 4.84%	86,600 $2.7 Million
Q3 2017 Nov 15, 2017	BUY	$11.61 - $31.21 $958,986 - $2.58 Million	82,600	82,600 $2.58 Million

Others Institutions Holding INSM

# of Institutions

489

Shares Held

197M

Call Options Held

892K

Put Options Held

1.77M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $13.2B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account

California Public Employees Retirement System Insmed Inc Transaction History